In plain English, these drugs slow your digestive system, stretching out the satiety and fullness you get from eating a meal
Hormonal changes, particularly a drop in estrogen, can play a major role in the health of these tissues
While data is still being collected and reviewed, the SELECT trial demonstrated a 20% relative reduction in major adverse cardiovascular events in patients treated with semaglutide
The Long-Term View Long weight is not just medical
Current status: Phase 3 trials (expected to continue through 2025-2026) FDA approval timeline: Likely 2026-2027 at the earliest What needs to happen first: Complete Phase 3 trials in larger populations Gather long-term safety data FDA review and approval process Manufacturing scale-up So while the results are exciting, we're still a few years away from retatrutide being available by prescription
There is increasing evidence to suggest that GLP-1 drugs may help people cut back on alcohol, smoking, and even opioid use